Core Viewpoint - Dentsply International (XRAY) is expected to report a decline in quarterly earnings and revenues, with analysts predicting earnings of 919.36 million, reflecting a 9.2% decline compared to the previous year [1]. Earnings Estimates - The consensus EPS estimate for the quarter has remained unchanged over the past 30 days, indicating that analysts have not revised their initial projections during this period [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock price performance [3]. Revenue Projections - Analysts estimate 'Net sales- Connected Technology Solutions' to be 76.04 million, indicating a slight increase of 0.1% from the same quarter last year [5]. - 'Net sales- Essential Dental Solutions' is expected to be 207.43 million, showing a significant decline of 19.9% compared to the prior year [6]. - 'Revenues- Rest of World' is projected to be 368.16 million, reflecting a decline of 7.3% year-over-year [7]. Stock Performance - Over the past month, Dentsply shares have recorded a return of -2.9%, compared to a -1.8% change in the Zacks S&P 500 composite [7]. - Based on its Zacks Rank 4 (Sell), Dentsply is likely to underperform the overall market in the upcoming period [7].
Dentsply (XRAY) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates